|Bid||84.65 x 373700|
|Ask||83.00 x 1281100|
|Day's Range||83.35 - 84.05|
|52 Week Range||69.50 - 85.40|
|PE Ratio (TTM)||29.85|
|Forward Dividend & Yield||2.73 (3.17%)|
|1y Target Est||N/A|
The last time Novartis AG hired a new chief, the drugmaker went with a guy who spent years at companies that make bleach and ketchup. This time around, the Swiss company chose someone with a deep understanding ...
U.S. regulators approved a revolutionary new cancer treatment from Novartis AG on Wednesday, the first in a group of coming therapies that offer breakthrough cures for dire cases as well as stratospheric ...
Novartis AG began testing a new anti-malaria pill in Africa, advancing development of an alternative to its most effective treatment that billionaire philanthropist Bill Gates said risked losing potency....